11:30 EDT Novartis (NVS) loses bid to block MSN generic of Entresto, Bloomberg says
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVS:
- FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
- Pan-Tumor Rollover Study: A New Horizon in Cancer Treatment
- Sironax grants Novartis exclusive option to acquire BDM platform
- Novartis (NVS) Wins Landmark Approval for Baby Malaria Treatment
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!